Literature DB >> 10519596

Treatment of persistent corneal epithelial defect by autologous serum application.

K Tsubota1, E Goto, S Shimmura, J Shimazaki.   

Abstract

OBJECTIVE: To evaluate the efficacy of autologous serum application for the treatment of persistent epithelial defect.
DESIGN: Prospective, clinical, noncomparative case series. PARTICIPANTS: A total of 16 eyes were studied. INTERVENTION: Autologous serum was prepared from the patients and diluted to 20% by saline. The patients were instructed to use the autologous serum six to ten times a day. The concentration of vitamin A, epidermal growth factor (EGF), and transforming growth factor-beta (TGF-beta) was measured at 1 week and 1 month stored in the refrigerator and 1 month and 3 months in the freezer. MAIN OUTCOME MEASURES: Time to closure of epithelial defect.
RESULTS: Vitamin A, EGF, and TGF-beta were stable during the 1 month in the refrigerator and 3 months in the freezer. Among 16 persistent epithelial defects, 7 (43.8%) healed within 2 weeks, 3 (18.8%) healed within 1 month, and the remaining 6 (37.5%) did not respond within 1 month. No apparent side effect of autologous serum application was observed.
CONCLUSIONS: Autologous serum application healed 43.8% of persistent defect within 2 weeks and 62.5% within 1 month.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10519596     DOI: 10.1016/S0161-6420(99)90412-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  72 in total

1.  The ocular surface toxicity of paraquat.

Authors:  D McKeag; R Maini; H R Taylor
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

2.  Differential contributions of impaired corneal sensitivity and reduced tear secretion to corneal epithelial disorders.

Authors:  Teruo Nishida; Tai-Ichiro Chikama; Mitsuru Sawa; Kazunori Miyata; Takaaki Matsui; Kyoko Shigeta
Journal:  Jpn J Ophthalmol       Date:  2011-11-11       Impact factor: 2.447

3.  Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects.

Authors:  R B Vajpayee; N Mukerji; R Tandon; N Sharma; R M Pandey; N R Biswas; N Malhotra; S A Melki
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

4.  Role of autologous serum in persistent epithelial defects.

Authors:  N Mukerji; R Sinha; R B Vajpayee
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

5.  [Epitheliotrophic capacity of serum and plasma eyedrops. Influence of centrifugation].

Authors:  P Herminghaus; G Geerling; D Hartwig; T Wedel; L Dibbelt
Journal:  Ophthalmologe       Date:  2004-10       Impact factor: 1.059

6.  An optimised protocol for the production of autologous serum eyedrops.

Authors:  L Liu; D Hartwig; S Harloff; P Herminghaus; T Wedel; G Geerling
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-09       Impact factor: 3.117

7.  A novel use of amniotic membrane in the management of tube exposure following glaucoma tube shunt surgery.

Authors:  G Ainsworth; A Rotchford; H S Dua; A J King
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

Review 8.  Autologous serum eye drops for ocular surface disorders.

Authors:  G Geerling; S Maclennan; D Hartwig
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

9.  A Case of Neurotrophic Keratopathy Concomitant to Brain Metastasis.

Authors:  Chiara Bonzano; Elisabetta Bonzano; Carlo Alberto Cutolo; Riccardo Scotto; Carlo Enrico Traverso
Journal:  Cureus       Date:  2018-03-12

Review 10.  [Current and experimental treatment approaches for neurotrophic keratopathy].

Authors:  J Alder; S Mertsch; J Menzel-Severing; G Geerling
Journal:  Ophthalmologe       Date:  2019-02       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.